Results 291 to 300 of about 303,848 (355)
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley +1 more source
Polymorphic variants of the dopamine receptor gene DRD2 (rs6277, rs1800497) in adolescents with problematic video game use. [PDF]
Tereshchenko SY +4 more
europepmc +1 more source
Fusion Pores as Regulators of Quantal Size and Cellular Physiology
During regulated exocytosis, membrane fusion regulatory factors act directly on SNAREs and membrane lipids to control fusion pore dynamics. This, in turn, leads to a differential amount of cargo release (referred to in this article as “quantal size”) across various cell types, thereby triggering distinct physiological cues.
Bhavya R. Bhaskar +3 more
wiley +1 more source
D2 dopamine receptor expression, reactivity to rewards, and reinforcement learning in a complex value-based decision-making task. [PDF]
Banuelos C +5 more
europepmc +1 more source
PM2.5 exposure contributes to anxiety and depression-like behaviors via phenyl-containing compounds interfering with dopamine receptor. [PDF]
Ji S +9 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Dopamine receptor pharmacology
Trends in Pharmacological Sciences, 1994Although antipsychotic drugs originally helped to discover dopamine receptors, the five dopamine receptors presently identified and cloned are facilitating the search for and discovery of more selective antipsychotic and antiparkinson drugs. The D1-like dopamine receptors, D1 and D5, are sensitive to the same drugs as the D1 receptor in native tissues,
Philip Seeman, Hubert H.M. Van Tol
openaire +4 more sources
A Comparison of the Vascular Dopamine Receptor with Other Dopamine Receptors
Annual Review of Pharmacology and Toxicology, 1978The dopamine (DA) receptor has had an interesting history. Unusual actions were attributed to the catecholamine for many years, but these effects were generally considered to be manifestations of activation of 0.and ,8-adrenergic receptors rather thap results of action of DA on a specific receptor (1). The pendulum now has swung the other way.
P H Volkman, J D Kohli, L I Goldberg
openaire +3 more sources

